K16I (p.Lys16Ile) variant of TSLP (Thymic stromal lymphopoietin)

K16I (p.Lys16Ile) in TSLP (Thymic stromal lymphopoietin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.20 / 1. The record also includes population frequency data and structural context.

K16I (p.Lys16Ile) variant details